Summary
81 / 100 · Bulios Score
What speaks for it
- Out of every 100 USD of revenue, 54 USD is left as net profit.
- The share price is below the Bulios Fair Price.
- Earnings per share grew by 13% a year over the last 3 years.
- It bought back its own shares for $105.1M in the last fiscal year, 3.4% of its market value.
What to watch
None of the indicators we track raises a caution right now.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 7.8 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 10% a year over 5 years. Over the last 3 years it grew by 10% a year. Earnings per share grew by 13% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 8.3 USD
- Sales and administration 22 USD
- Taxes and other 15 USD
- Net profit 54 USD
Net profit, industry median (Insurance - Specialty) 14 USD
Out of every 100 USD of revenue, 54 USD is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 16
- Hold 4
- Sell 0
Today's price within the analysts' price targets
The average target of $49.5 is 16% above today's price. 80% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.